Cargando…
The PRMT5/WDR77 complex restricts hepatitis E virus replication
Hepatitis E virus (HEV) is one of the main pathogenic agents of acute hepatitis in the world. The mechanism of HEV replication, especially host factors governing HEV replication is still not clear. Here, using HEV ORF1 trans-complementation cell culture system and HEV replicon system, combining with...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270597/ https://www.ncbi.nlm.nih.gov/pubmed/37276230 http://dx.doi.org/10.1371/journal.ppat.1011434 |
_version_ | 1785059347629342720 |
---|---|
author | Ju, Xiaohui Yu, Yanying Ren, Wenlin Dong, Lin Meng, Xianbin Deng, Haiteng Nan, Yuchen Ding, Qiang |
author_facet | Ju, Xiaohui Yu, Yanying Ren, Wenlin Dong, Lin Meng, Xianbin Deng, Haiteng Nan, Yuchen Ding, Qiang |
author_sort | Ju, Xiaohui |
collection | PubMed |
description | Hepatitis E virus (HEV) is one of the main pathogenic agents of acute hepatitis in the world. The mechanism of HEV replication, especially host factors governing HEV replication is still not clear. Here, using HEV ORF1 trans-complementation cell culture system and HEV replicon system, combining with stable isotope labelling with amino acids in cell culture (SILAC) and mass spectrometry (MS), we aimed to identify the host factors regulating HEV replication. We identified a diversity of host factors associated with HEV ORF1 protein, which were putatively responsible for viral genomic RNA replication, in these two cell culture models. Of note, the protein arginine methyltransferase 5 (PRMT5)/WDR77 complex was identified in both cell culture models as the top hit. Furthermore, we demonstrated that PRMT5 and WDR77 can specifically inhibit HEV replication, but not other viruses such as HCV or SARS-CoV-2, and this inhibition is conserved among different HEV strains and genotypes. Mechanistically, PRMT5/WDR77 can catalyse methylation of ORF1 on its R458, impairing its replicase activity, and virus bearing R458K mutation in ORF1 relieves the restriction of PRMT5/WDR77 accordingly. Taken together, our study promotes more comprehensive understanding of viral infections but also provides therapeutic targets for intervention. |
format | Online Article Text |
id | pubmed-10270597 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-102705972023-06-16 The PRMT5/WDR77 complex restricts hepatitis E virus replication Ju, Xiaohui Yu, Yanying Ren, Wenlin Dong, Lin Meng, Xianbin Deng, Haiteng Nan, Yuchen Ding, Qiang PLoS Pathog Research Article Hepatitis E virus (HEV) is one of the main pathogenic agents of acute hepatitis in the world. The mechanism of HEV replication, especially host factors governing HEV replication is still not clear. Here, using HEV ORF1 trans-complementation cell culture system and HEV replicon system, combining with stable isotope labelling with amino acids in cell culture (SILAC) and mass spectrometry (MS), we aimed to identify the host factors regulating HEV replication. We identified a diversity of host factors associated with HEV ORF1 protein, which were putatively responsible for viral genomic RNA replication, in these two cell culture models. Of note, the protein arginine methyltransferase 5 (PRMT5)/WDR77 complex was identified in both cell culture models as the top hit. Furthermore, we demonstrated that PRMT5 and WDR77 can specifically inhibit HEV replication, but not other viruses such as HCV or SARS-CoV-2, and this inhibition is conserved among different HEV strains and genotypes. Mechanistically, PRMT5/WDR77 can catalyse methylation of ORF1 on its R458, impairing its replicase activity, and virus bearing R458K mutation in ORF1 relieves the restriction of PRMT5/WDR77 accordingly. Taken together, our study promotes more comprehensive understanding of viral infections but also provides therapeutic targets for intervention. Public Library of Science 2023-06-05 /pmc/articles/PMC10270597/ /pubmed/37276230 http://dx.doi.org/10.1371/journal.ppat.1011434 Text en © 2023 Ju et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Ju, Xiaohui Yu, Yanying Ren, Wenlin Dong, Lin Meng, Xianbin Deng, Haiteng Nan, Yuchen Ding, Qiang The PRMT5/WDR77 complex restricts hepatitis E virus replication |
title | The PRMT5/WDR77 complex restricts hepatitis E virus replication |
title_full | The PRMT5/WDR77 complex restricts hepatitis E virus replication |
title_fullStr | The PRMT5/WDR77 complex restricts hepatitis E virus replication |
title_full_unstemmed | The PRMT5/WDR77 complex restricts hepatitis E virus replication |
title_short | The PRMT5/WDR77 complex restricts hepatitis E virus replication |
title_sort | prmt5/wdr77 complex restricts hepatitis e virus replication |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10270597/ https://www.ncbi.nlm.nih.gov/pubmed/37276230 http://dx.doi.org/10.1371/journal.ppat.1011434 |
work_keys_str_mv | AT juxiaohui theprmt5wdr77complexrestrictshepatitisevirusreplication AT yuyanying theprmt5wdr77complexrestrictshepatitisevirusreplication AT renwenlin theprmt5wdr77complexrestrictshepatitisevirusreplication AT donglin theprmt5wdr77complexrestrictshepatitisevirusreplication AT mengxianbin theprmt5wdr77complexrestrictshepatitisevirusreplication AT denghaiteng theprmt5wdr77complexrestrictshepatitisevirusreplication AT nanyuchen theprmt5wdr77complexrestrictshepatitisevirusreplication AT dingqiang theprmt5wdr77complexrestrictshepatitisevirusreplication AT juxiaohui prmt5wdr77complexrestrictshepatitisevirusreplication AT yuyanying prmt5wdr77complexrestrictshepatitisevirusreplication AT renwenlin prmt5wdr77complexrestrictshepatitisevirusreplication AT donglin prmt5wdr77complexrestrictshepatitisevirusreplication AT mengxianbin prmt5wdr77complexrestrictshepatitisevirusreplication AT denghaiteng prmt5wdr77complexrestrictshepatitisevirusreplication AT nanyuchen prmt5wdr77complexrestrictshepatitisevirusreplication AT dingqiang prmt5wdr77complexrestrictshepatitisevirusreplication |